Status:
UNKNOWN
Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients
Lead Sponsor:
Shahid Beheshti University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
22-25 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compo...
Detailed Description
The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compo...
Eligibility Criteria
Inclusion
- PCOS patients
Exclusion
- Women who received hormone therapy during the last 3 months,
- On a diet
- Herbal treatment
- Hyperprolactinemia
- Thyroid disorders
- Ovarian tumors
- Cushing disease.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00955058
Start Date
February 1 2007
End Date
December 1 2010
Last Update
September 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taheripanah
Tehran, Tehran Province, Iran, 14137